Consistently, TFAP2A enhanced the protein levels of cancer stem cell markers and stemness-related genes, including CD44, CD133, NANOG, OCT-4A and SOX2 (Figures 3H, 3I, and S3I). This evidence concerns the gene CD44 and cancer.